Newsroom
RTI International was recently awarded a new contract, “Tracking and Evaluation of State Policies Related to Medication Assisted Treatment (MAT),” for the Centers for Disease Control and Prevention (CDC) to identify and assess the impact of federal and state laws that influence the use of medication for treating opioid use disorder (MOUD).
Led by RTI expert Arnie Aldridge, this new project will include a legal and impact analysis to create a database of historical and current measures that directly affect providers’ and patients’ use of MAT. Characterizing and measuring the impact of the legal landscape on MOUD use will help federal and state policy makers identify barriers that can be removed to improve the opioid epidemic.
Learn more about RTI’s research related to treating opioid use disorders.
RTI International is an independent, scientific research institute dedicated to improving the human condition. Our vision is to address the world's most critical problems with technical and science-based solutions in pursuit of a better future. Clients rely on us to answer questions that demand an objective and multidisciplinary approach—one that integrates expertise across social, statistical, data, and laboratory sciences, engineering, and other technical disciplines to solve the world’s most challenging problems.
For more information, visit www.rti.org.